Prediction: SpaceX Will Reach This Price in July (Hint: It's Going to Plummet)

SpaceX is facing a potential supply shock at its first post-IPO earnings report, when up to 20% of eligible insider shares, or about 911 million shares, can begin unlocking. The article argues the stock could fall back toward the $150 IPO price if roughly 30% of eligible shares are sold, with further downside possible as additional tranches expire. The near-term setup is presented as a high-risk entry point despite long-term optimism around Starlink and AI infrastructure.

Analysis

The near-term setup is less about fundamentals than about float mechanics: when a newly public name trades on narrative more than earnings, the first meaningful unlock often acts like an implied secondary offering without an underwriter. That matters because the marginal seller in the first tranche is not just insiders monetizing; it is also the cohort that bought IPO-adjacent exposure at inflated implied multiples and will use liquidity to de-risk if price momentum stalls. In that regime, price discovery tends to overshoot on the downside before stabilizing, especially when early buyers are mostly momentum-driven and less sticky than long-only fundamental capital.

The second-order beneficiary is the exchange/capital-markets complex, not the stock itself. Elevated turnover and volatility support options volume, market-making spreads, and index/benchmark rebalancing activity around the name; NDAQ should see a small but real flow lift from heightened trading in a high-profile listing. Competitively, a post-unlock drawdown in the high-visibility growth asset can temporarily re-rate other long-duration names in the space by tightening the discount rate applied to “story stocks,” which may pressure adjacent high-multiple software/AI infrastructure exposures even if their fundamentals are unchanged.

The key catalyst path is binary over days, then more gradual over months. In the first 1-2 weeks after earnings, the market will test whether natural buyers can absorb sell-side inventory without a sharp air pocket; if not, the stock can gap down quickly because expected supply is being brought forward into a thin marginal demand window. Over the following quarter, successive unlock tranches create a rolling overhang, which means any rally into unlock dates is likely to be sold unless the company delivers a genuine step-change in revenue quality that expands the buyer base beyond event-driven traders.

Key Decisions for Investors

• Avoid initiating new long exposure in SPCX into the first earnings/unlock window; wait 1-2 sessions after the unlock to see whether volume is absorbed or the stock breaks below post-IPO support. Risk/reward is poor until the supply overhang is price-discovered.
• If your mandate allows, buy near-dated SPCX puts or put spreads into the earnings date to express the unlock event with defined risk; best setup is a 2-6 week tenor where time decay is offset by volatility expansion if the stock gaps lower.
• Consider a relative-value short SPCX / long quality growth basket trade for the unlock period, targeting names with similar duration but cleaner floats. This captures event-specific supply pressure while neutralizing broad factor risk.
• Tactically overweight NDAQ on a 1-2 month horizon as a secondary beneficiary of elevated trading and options activity around a marquee unlock. The upside is modest, but the flow tailwind is more durable than the one-time price reaction in SPCX.
• Set a re-entry alert only after the first post-unlock stabilization above the market-clearing level; if SPCX fails to reclaim its post-earnings range within 3-5 trading days, expect the next unlock tranche to cap rallies and favor staying sidelined.